{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T21:07:30Z","timestamp":1782940050568,"version":"3.54.5"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>\n                    The glutamatergic modulator ketamine rapidly reduces depressive symptoms in individuals with treatment-resistant major depressive disorder (TRD) and bipolar disorder. While its underlying mechanism of antidepressant action is not fully understood, modulating glutamatergically-mediated connectivity appears to be a critical component moderating antidepressant response. This double-blind, crossover, placebo-controlled study analyzed data from 19 drug-free individuals with TRD and 15 healthy volunteers who received a single intravenous infusion of ketamine hydrochloride (0.5 mg\/kg) as well as an intravenous infusion of saline placebo. Magnetoencephalographic recordings were collected prior to the first infusion and 6\u20139 h after both drug and placebo infusions. During scanning, participants completed an attentional dot probe task that included emotional faces. Antidepressant response was measured across time points using the Montgomery-Asberg Depression Rating Scale (MADRS). Dynamic causal modeling (DCM) was used to measure changes in parameter estimates of connectivity\n                    <jats:italic>via<\/jats:italic>\n                    a biophysical model that included realistic local neuronal architecture and receptor channel signaling, modeling connectivity between the early visual cortex, fusiform cortex, amygdala, and inferior frontal gyrus. Clinically, ketamine administration significantly reduced depressive symptoms in TRD participants. Within the model, ketamine administration led to faster gamma aminobutyric acid (GABA) and N-methyl-D-aspartate (NMDA) transmission in the early visual cortex, faster NMDA transmission in the fusiform cortex, and slower NMDA transmission in the amygdala. Ketamine administration also led to direct and indirect changes in local inhibition in the early visual cortex and inferior frontal gyrus and to indirect increases in cortical excitability within the amygdala. Finally, reductions in depressive symptoms in TRD participants post-ketamine were associated with faster \u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) transmission and increases in gain control of spiny stellate cells in the early visual cortex. These findings provide additional support for the GABA and NMDA inhibition and disinhibition hypotheses of depression and support the role of AMPA throughput in ketamine's antidepressant effects.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Clinical Trial Registration:<\/jats:bold>\n                    <jats:ext-link>https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00088699?term=NCT00088699&amp;amp;draw=2&amp;amp;rank=1<\/jats:ext-link>\n                    , identifier NCT00088699.\n                  <\/jats:p>","DOI":"10.3389\/fpsyt.2021.673159","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T01:09:14Z","timestamp":1623978554000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Ketamine and Attentional Bias Toward Emotional Faces: Dynamic Causal Modeling of Magnetoencephalographic Connectivity in Treatment-Resistant Depression"],"prefix":"10.3389","volume":"12","author":[{"given":"Jessica R.","family":"Gilbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina S.","family":"Galiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison C.","family":"Nugent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Zarate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/mp.2010.44","article-title":"Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression","volume":"16","author":"Bernard","year":"2011","journal-title":"Mol Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","first-page":"15653","DOI":"10.1073\/pnas.0507901102","article-title":"Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression","volume":"102","author":"Choudary","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/mp.2010.120","article-title":"The GABAergic deficit hypothesis of major depressive disorder","volume":"16","author":"Luscher","year":"2011","journal-title":"Mol Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.biopsych.2009.12.004","article-title":"Markers of glutamate synaptic transmission and plasticity are increased in the anterior cingulate cortex in bipolar disorder","volume":"67","author":"Eastwood","year":"2010","journal-title":"Biol Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2174\/1566524015666150330143008","article-title":"Glutamate signaling in synaptogenesis and NMDA receptors as potential therapeutic targets for psychiatric disorders","volume":"15","author":"Ohgi","year":"2015","journal-title":"Curr Mol Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","first-page":"6441","DOI":"10.1073\/pnas.1819540116","article-title":"(2R,6R)-hydroxynorketamine exerts mGlu2 receptor-dependent antidepressant actions","volume":"116","author":"Zanos","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am J Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biol Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1176\/appi.ajp.2018.18070834","article-title":"Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: a randomized controlled trial","volume":"176","author":"Phillips","year":"2019","journal-title":"Am J Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.1073\/pnas.1816071116","article-title":"Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function","volume":"116","author":"Lumsden","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B13","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J Neurosci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"11496","DOI":"10.1523\/JNEUROSCI.2213-07.2007","article-title":"NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons","volume":"27","author":"Homayoun","year":"2007","journal-title":"J Neurosci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.neuron.2019.03.013","article-title":"Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments","volume":"102","author":"Duman","year":"2019","journal-title":"Neuron"},{"key":"B17","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.biopsych.2010.12.015","article-title":"Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure","volume":"69","author":"Li","year":"2011","journal-title":"Biol Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.biopsych.2011.09.030","article-title":"Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex","volume":"71","author":"Liu","year":"2012","journal-title":"Biol Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.biopsych.2012.09.006","article-title":"The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine","volume":"73","author":"Monteggia","year":"2013","journal-title":"Biol Psychiatry"},{"key":"B22","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.neuron.2020.05.015","article-title":"Targeting homeostatic synaptic plasticity for treatment of mood disorders","volume":"106","author":"Kavalali","year":"2020","journal-title":"Neuron"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e03581","DOI":"10.7554\/eLife.03581","article-title":"GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine","volume":"3","author":"Miller","year":"2014","journal-title":"eLife"},{"key":"B24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fncel.2019.00087","article-title":"Cortical GABAergic dysfunction in stress and depression: new insights for therapeutic interventions","volume":"13","author":"Foga\u00e7a","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jpsychires.2018.08.015","article-title":"Differences in excitatory and inhibitory neurotransmitter levels between depressed patients and healthy controls: a systematic review and meta-analysis","volume":"105","author":"Godfrey","year":"2018","journal-title":"J Psychiatr Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"E3007","DOI":"10.1073\/pnas.1718883115","article-title":"Disinhibition of CA1 pyramidal cells by low-dose ketamine and other antagonists with rapid antidepressant efficacy","volume":"115","author":"Widman","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e1002354","DOI":"10.1371\/journal.pcbi.1002354","article-title":"Membrane properties and the balance between excitation and inhibition control gamma-frequency oscillations arising from feedback inhibition","volume":"8","author":"Economo","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.tics.2014.12.002","article-title":"Do gamma oscillations play a role in cerebral cortex?","volume":"19","author":"Ray","year":"2015","journal-title":"Trends Cogn Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-neuro-062111-150444","article-title":"Mechanisms of gamma oscillations","volume":"35","author":"Buzs\u00e1ki","year":"2012","journal-title":"Ann Rev Neurosci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"11694","DOI":"10.1523\/JNEUROSCI.0903-15.2015","article-title":"Evidence that subanesthetic doses of ketamine cause sustained disruptions of NMDA and AMPA-mediated frontoparietal connectivity in humans","volume":"35","author":"Muthukumaraswamy","year":"2015","journal-title":"J Neurosci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.euroneuro.2015.04.012","article-title":"Ketamine amplifies induced gamma frequency oscillations in the human cerebral cortex","volume":"25","author":"Shaw","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.biopsych.2012.03.029","article-title":"Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression","volume":"72","author":"Cornwell","year":"2012","journal-title":"Biol Psychiatry"},{"key":"B33","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/mp.2013.130","article-title":"Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects","volume":"19","author":"Sanacora","year":"2014","journal-title":"Mol Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/s41380-018-0028-2","article-title":"Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects","volume":"24","author":"Nugent","year":"2019","journal-title":"Mol Psychiatry"},{"key":"B35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.pscychresns.2018.09.001","article-title":"Synaptic potentiation and rapid antidepressant response to ketamine in treatment-resistant major depression: a replication study","volume":"283","author":"Nugent","year":"2019","journal-title":"Psychiatry Res Neuroimaging"},{"key":"B36","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/0272-7358(90)90098-U","article-title":"Biases of attention and memory in disorders of anxiety and depression","volume":"10","author":"Dalgleish","year":"1990","journal-title":"Clin Psychol Rev"},{"key":"B37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1146\/annurev.ps.45.020194.000325","article-title":"Cognitive approaches to emotion and dmotional disorders","volume":"45","author":"Mathews","year":"1994","journal-title":"Ann Rev Psychol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1037\/0021-843X.113.1.121","article-title":"Attentional biases for negative interpersonal stimuli in clinical depression","volume":"113","author":"Gotlib","year":"2004","journal-title":"J Abnorm Psychol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1037\/0021-843X.116.1.80","article-title":"Selective attention to emotional faces following recovery from depression","volume":"116","author":"Joormann","year":"2007","journal-title":"J Abnorm Psychol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/mp.2014.24","article-title":"Neuropsychological mechanism underlying antidepressant effect: a systematic meta-analysis","volume":"20","author":"Ma","year":"2015","journal-title":"Mol Psychiatry"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1002\/da.20755","article-title":"A meta-analysis of the magnitude of biased attention in depression","volume":"27","author":"Peckham","year":"2010","journal-title":"Depress Anxiety"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2045-5380-2-1","article-title":"Functional anomalies in healthy individuals with a first degree family history of major depressive disorder","volume":"2","author":"Amico","year":"2012","journal-title":"Biol Mood Anxiety Disord"},{"key":"B43","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.nicl.2018.07.006","article-title":"Ketamine normalizes brain activity during emotionally valenced attentional processing in depression","volume":"20","author":"Reed","year":"2018","journal-title":"NeuroImage Clin"},{"key":"B44","doi-asserted-by":"publisher","first-page":"13530","DOI":"10.1038\/s41598-017-13626-3","article-title":"Emotion regulating attentional control abnormalities in major depressive disorder: an event-related potential study","volume":"7","author":"Hu","year":"2017","journal-title":"Sci Rep"},{"key":"B45","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.biopsych.2015.06.012","article-title":"Frontal cortex stimulation reduces vigilance to threat: implications for the treatment of depression and anxiety","volume":"79","author":"Ironside","year":"2016","journal-title":"Biol Psychiatry"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.cub.2011.06.053","article-title":"An in vivo assay of synaptic function mediating human cognition","volume":"21","author":"Moran","year":"2011","journal-title":"Curr Biol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"172856","DOI":"10.1016\/j.pbb.2020.172856","article-title":"Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: gamma power and long-term potentiation","volume":"189","author":"Gilbert","year":"2020","journal-title":"Pharmacol Biochem Behav"},{"key":"B48","year":"1994"},{"key":"B49","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"B50","volume-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I\/P)","author":"First","year":"2002"},{"key":"B51","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/npp.2009.168","article-title":"Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine","volume":"35","author":"Hong","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1162\/jocn.2009.21305","article-title":"Ketamine modulates theta and gamma oscillations","volume":"22","author":"Lazarewicz","year":"2010","journal-title":"J Cogn Neurosci"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.neuroimage.2005.10.045","article-title":"Dynamic causal modeling of evoked responses in EEG and MEG","volume":"30","author":"David","year":"2006","journal-title":"NeuroImage"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1093\/brain\/awy107","article-title":"Ion channels in EEG: isolating channel dysfunction in NMDA receptor antibody encephalitis","volume":"141","author":"Symmonds","year":"2018","journal-title":"Brain"},{"key":"B55","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/npp.2014.184","article-title":"Losing control under ketamine: suppressed cortico-hippocampal drive following acute ketamine in rats","volume":"40","author":"Moran","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/ijnp\/pyy041","article-title":"Glutamatergic signaling drives ketamine-mediated response in depression: evidence from dynamic causal modeling","volume":"21","author":"Gilbert","year":"2018","journal-title":"Int J Neuropsychopharmacol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.bpsc.2019.11.011","article-title":"Magnetoencephalographic correlates of suicidal ideation in major depression","volume":"5","author":"Gilbert","year":"2020","journal-title":"Biol Psychiatr"},{"key":"B58","doi-asserted-by":"publisher","first-page":"13232","DOI":"10.1523\/JNEUROSCI.3481-07.2007","article-title":"Magnocellular projections as the trigger of top-down facilitation in recognition","volume":"27","author":"Kveraga","year":"2007","journal-title":"J Neurosci"},{"key":"B59","doi-asserted-by":"publisher","first-page":"31943","DOI":"10.1038\/srep31943","article-title":"Inputs to prefrontal cortex support visual recognition in the aging brain","volume":"6","author":"Gilbert","year":"2016","journal-title":"Sci Rep"},{"key":"B60","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S0896-6273(02)01091-7","article-title":"View from the top: hierarchies and reverse hierarchies in the visual system","volume":"36","author":"Hochstein","year":"2002","journal-title":"Neuron"},{"key":"B61","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.neuroimage.2006.08.035","article-title":"Variational free energy and the Laplace approximation","volume":"34","author":"Friston","year":"2007","journal-title":"Neuroimage"},{"key":"B62","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.neuroimage.2015.11.015","article-title":"Bayesian model reduction and empirical Bayes for group (DCM) studies","volume":"128","author":"Friston","year":"2016","journal-title":"Neuroimage"},{"key":"B63","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1523\/JNEUROSCI.12-09-03628.1992","article-title":"A functional anatomical study of unipolar depression","volume":"12","author":"Drevets","year":"1992","journal-title":"J Neurosci"},{"key":"B64","doi-asserted-by":"publisher","first-page":"117189","DOI":"10.1016\/j.neuroimage.2020.117189","article-title":"Generative modelling of the thalamo-cortical circuit mechanisms underlying the neurophysiological effects of ketamine","volume":"221","author":"Shaw","year":"2020","journal-title":"NeuroImage"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.673159\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T01:09:17Z","timestamp":1623978557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.673159\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,18]]},"references-count":64,"alternative-id":["10.3389\/fpsyt.2021.673159"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2021.673159","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.02.22.21252247","asserted-by":"object"}]},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,18]]},"article-number":"673159"}}